Highlights Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 03:59:52 2024-05-29 pm EDT			5-day change	1st Jan Change
1.83 ^USD	-2.40%		-1.08%	-81.35%

May. 15	Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	MT
May. 15	Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	May. 15	MT
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	May. 15	CI
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M	May. 09	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Sector Update: Health Care Stocks Higher Late Afternoon	Apr. 16	MT
Sector Update: Health Care	Apr. 16	MT
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	Apr. 16	MT
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	Apr. 16	CI
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	Mar. 27	CI
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	Mar. 12	CI
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	Feb. 15	MT
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M	Feb. 15	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	Feb. 05	CI
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions	Jan. 15	CI
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue	Jan. 08	MT
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders	Nov. 02	CI
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research	Nov. 01	MT
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible	Nov. 01	CI
Pacific Biosciences of California Q3 Loss Narrows, Revenue Gains	23-10-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Highlights

Filters